Home › Funds › Silverberg Bernstein Capital Management LLC › PHAR

Silverberg Bernstein Capital Management LLC position in PHAR

PHARMING GROUP NV · Health Care

Silverberg Bernstein Capital Management LLC reported holding 35,787 shares of PHAR (PHARMING GROUP NV) in its Q3 2026 13F filing — a position valued at US$358K, representing 0.17% of its reported portfolio and ranking #49 among its reported holdings. Silverberg Bernstein Capital Management LLC has disclosed PHAR holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)35.79K sh
Reported value held$357.51K
Portfolio Weight0.17%
First reportedQ4 2023
Last changeReduce
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How Silverberg Bernstein Capital Management LLC's PHAR position evolved

Silverberg Bernstein Capital Management LLC first disclosed a stake in PHAR in Q4 2023 at 17,710 shares (US$202K). The position peaked in Q4 2025 at 50,547 shares, worth US$893K. Across 12 filings, Silverberg Bernstein Capital Management LLC increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 35,787 shares valued at US$358K — a reduction of -5,760 shares quarter over quarter.. Notable position changes include a 32% increase in Q2 2024 (shares rose 21% over the following quarter), a 75% increase in Q3 2024.

Quarter by quarter

QuarterSharesValueChange
Q4 2023 17.71K $202.43K New
Q1 2024 17.71K $185.96K Hold
Q2 2024 23.43K $195.68K Add
Q3 2024 41.11K $339.16K Add
Q4 2024 48.00K $483.09K Add
Q1 2025 48.00K $401.55K Hold
Q2 2025 52.15K $557.45K Add
Q3 2025 52.15K $756.13K Hold
Q4 2025 50.55K $893.16K Reduce
Q1 2026 44.75K $744.59K Reduce
Q2 2026 41.55K $577.09K Reduce
Q3 2026 35.79K $357.51K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PHAR and 13F data

PHAR (PHARMING GROUP NV) is a Health Care company. 15 other funds we track also report a position in PHAR — the largest reported positions include Knoll Capital Management, LLC (US$57K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PHAR

All PHAR fund holders →

FAQ

How long has Silverberg Bernstein Capital Management LLC held PHAR?

Silverberg Bernstein Capital Management LLC has disclosed PHAR holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is Silverberg Bernstein Capital Management LLC's current position in PHAR?

As of Q3 2026, Silverberg Bernstein Capital Management LLC holds 35.79K shares of PHAR (PHARMING GROUP NV), valued at $357.51K, representing 0.17% of its reported portfolio and ranking #49.

Has Silverberg Bernstein Capital Management LLC been buying or selling PHAR?

In the latest 13F filing (Q3 2026), Silverberg Bernstein Capital Management LLC reduced its position in PHAR. The position peaked in Q4 2025 at 50.55K shares.

Which other funds hold PHAR?

Other major institutional holders of PHAR include Knoll Capital Management, LLC, among 15 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.